Accelerate your immunology startup from Marseille to the world
Join the first cohort of the MIB Startup Studio: a programme designed for already founded immunology startups ready to scale and connect with a leading scientific, clinical and industrial ecosystem.
€ 96M
ANCHORED IN THE BIOCLUSTER
A France 2030 initiative led by Aix-Marseille University.
Marseille Immunology Biocluster brings together a consortium of 10 founding members across academia, hospitals, industry, innovation and public institutions — with one ambition: positioning Marseille among the world’s leading centres for immunotherapy.
Rooted in more than 40 years of immunology research in Marseille, MIB connects scientific excellence, clinical expertise, technology platforms, industrial partners, investors and startups to accelerate new therapies for patients.
FOR IMMUNOLOGY STARTUPS READY FOR THEIR NEXT STAGE
This call is open to already founded startups with strong applications in immunology and a clear ambition to move to the next step: scale-up, clinical development, industrialisation, investment readiness or market access.
Applications may focus on:
Three Strategies for Scaling Up
Support the founders
Strategic mentoring, investment readiness, regulatory insights and access to experienced biotech, pharma and investor networks.
Grow the ecosystem
The studio connects scientific excellence, talent, industry ties and international mentors to strengthen the immunology innovation pipeline from Marseille.
The right environment
Technology platforms, clinical-trial expertise and a leading public-private ecosystem: the conditions immunology startups need to move from discovery to patients.
THE SELECTION PROCESS
Applications will be reviewed by a selection committee composed of scientific, industrial and innovation experts.
Projects will be assessed based on:
KEY DATES
READY TO SCALE YOUR IMMUNOLOGY STARTUP?
Join the first cohort of the MIB Startup Studio and become part of a leading immunology ecosystem connecting science, patients, industry and investors.
